# US 2001/0027188 A1 · Composition for prophylaxis and/or treatment of dry eye syndrome comprising vitamin D

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0027188 A1
- Document ID: US20010027188A1
- Status: Published application
- Kind: A1
- Application number: 09/784,147
- Filed: 2001-02-16
- Published: 2001-10-04
- Earliest claimed: 1997-06-10
- Assignees: New Vision Co., Ltd.
- Inventors: Seiji Itoh; Yasuo Ishii; Katsuhiko Mukai; Kiyoshi Kita
- Web page: https://patentgrep.com/patent/US20010027188A1

## CPC

- A61K 31/59: Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K 9/0048: {Eye, e.g. artificial tears}
- A61K 31/592: 9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
- A61K 31/593: 9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
- A61K 31/74: Synthetic polymeric materials
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

An ophthalmic composition for prophylaxis and/or treatment of keratoconjunctivitis sicca, which is locally administered to the eyes and which comprises, as an effective component, at least one member selected from the group consisting of vitamin D, active vitamin D, and active vitamin D analogues.

## Claims

### Claim 1

An ophthalmic composition for prophylaxis and/or treatment of keratoconjunctivitis sicca, which is locally administered to the eyes and which comprises, as an effective component, at least one member selected from the group consisting of vitamin D, active vitamin D, and active vitamin D analogues.

### Claim 2 (depends on 1)

The ophthalmic composition for prophylaxis and/or treatment of keratoconjunctivitis sicca of claim 1 wherein the composition is in the form of eye drops.

### Claim 3 (depends on 1)

The ophthalmic composition for prophylaxis and/or treatment of keratoconjunctivitis sicca of claim 1 wherein the effective component is at least one member selected from the group consisting of ergocalciferols, cholecalciferols, calcitriol (1α,25-dihydroxy vitamin D), 1α,24-dihydroxy vitamin D, 1α-calcidol (1α-monohydroxy vitamin D), calcifedol (25-monohydroxy vitamin D), 1α, 24, 25-trihydroxy vitamin D, 1β, 25-dihydroxy vitamin D, 22-oxacalcitriol, calcipotriol and dihydrotachysterol.

### Claim 4 (depends on 1)

The ophthalmic composition for prophylaxis and/or treatment of keratoconjunctivitis sicca of claim 1 wherein the effective component is 22-oxacalcitriol.
